Structural Heart Devices Market Report 2026

Structural Heart Devices Market Overview

• Structural Heart Devices market size has reached to $11.37 billion in 2025 • Expected to grow to $17.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases And The Structural Heart Device Market • Market Trend: Innovative Minimally Invasive Heart Valve Solutions Enhance Durability And Reduce Complications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Structural Heart Devices Market?

Structural heart devices are specialized medical implants or tools designed for the treatment of various structural defects or abnormalities affecting the heart. It is used to repair or replace damaged heart structures, such as valves or septa, restoring normal heart functions and improving patient outcomes. The main types of structural heart devices are heart valve devices, annuloplasty rings, occluders, and delivery systems. Heart valve devices are medical tools designed to repair or replace damaged heart valves, ensuring proper blood flow through the heart. The procedures include replacement procedures, repair procedures for indications such as atrial septal defect, patent foramen ovale, ventricular septal defect, aortic valve stenosis, and others for age group categories including pediatrics and adults.

What Is The Structural Heart Devices Market Growth Forecast?

The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $17.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing preference for minimally invasive procedures, rising investments in cardiovascular innovation, expansion of pediatric cardiac interventions, growing adoption of AI-assisted diagnostics, increasing demand for durable and long-lasting implants. Major trends in the forecast period include increasing adoption of transcatheter heart valve procedures, rising demand for minimally invasive cardiac implants, growing integration of advanced imaging and navigation systems, expansion of catheter-based delivery technologies, enhanced focus on patient-specific device design.

Global Structural Heart Devices Market Segmentation

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems 2) By Procedure: Replacement Procedures, Repair Procedures 3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications 4) By Age Group: Pediatric, Adults Subsegments: 1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings 2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings 3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders 4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

What Is The Driver Of The Structural Heart Devices Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the structural heart device market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. The cases of cardiovascular diseases, including heart disease and stroke, have been steadily increasing globally due to sedentary lifestyles, poor dietary habits, rising obesity rates, smoking, and aging populations. Structural heart devices treat cardiovascular diseases by repairing or replacing damaged heart valves, correcting structural defects, and improving heart function and patient outcomes. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the structural heart device industry.

Key Players In The Global Structural Heart Devices Market

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH

Global Structural Heart Devices Market Trends and Insights

Major companies in the structural heart devices market are focusing on developing innovative solutions, such as next-generation transcatheter heart valves, to improve durability, reduce complications, and expand minimally invasive treatment options. Next-generation transcatheter heart valves are minimally invasive replacement valves designed with advanced materials and features, such as anti-calcification tissue and improved sealing, to enhance durability and reduce complications compared to earlier valves. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, offering a durable, minimally invasive treatment for aortic stenosis in patients who are not candidates for open-heart surgery. Key features of this advanced valve include calcification-resistant tissue technology to prevent calcium buildup and improve longevity, a taller outer sealing skirt to reduce paravalvular leaks, and dry tissue storage for easier hospital handling. Furthermore, the platform supports a “lifetime management” strategy, enabling minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.

What Are Latest Mergers And Acquisitions In The Structural Heart Devices Market?

In October 2024, Johnson And Johnson, a US-based healthcare technology company, acquired V‑Wave Ltd. for an undisclosed amount. With this acquisition, Johnson & Johnson aims to strengthen its MedTech cardiovascular portfolio and accelerate its entry into high-growth heart‑failure treatment markets. V‑Wave Ltd., is Israel-based medical device company that provide provides structural heart devices

Regional Outlook

North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Structural Heart Devices Market?

The structural heart devices market consists of sales of paravalvular leak closure devices, endovascular stents, and percutaneous mitral valve replacement. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.